New Key Statistics Module, Z-Score and F-Score
NAS:HALO Key Ratios
| Market Cap $ M | 4,853.47 |
| Enterprise Value $ M | 5,967.17 |
| P/E(ttm) | 18.10 |
| PE Ratio without NRI | 17.52 |
| Forward PE Ratio | 12.47 |
| Price/Book | 57.88 |
| Price/Sales | 6.20 |
| Price/Free Cash Flow | 13.70 |
| Price/Owner Earnings | 14.04 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 829.00 |
| EPS (TTM) $ | 2.11 |
| Beneish M-Score | -2.82 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | 50.10 |
| EV-to-EBIT | 16.26 |
| EV-to-EBITDA | 13.20 |
| PEG | -- |
| Shares Outstanding M | 127.05 |
| Net Margin (%) | 33.96 |
| Operating Margin % | 40.71 |
| Pre-tax Margin (%) | 42.01 |
| Quick Ratio | 5.50 |
| Current Ratio | 6.64 |
| ROA % (ttm) | 15.68 |
| ROE % (ttm) | 195.64 |
| ROIC % (ttm) | 20.60 |
| Dividend Yield % | -- |
| Altman Z-Score | 3.44 |
| Piotroski F-Score | 6.00 |
| Positive ROA | Y |
| Positive CFROA | Y |
| Higher ROA y-y | N |
| Cash flow > Earnings | Y |
| Lower Leverage y-y | Y |
| Higher Current Ratio y-y | Y |
| Less Shares Outstanding y-y | Y |
| Gross Margin Increase y-y | N |
| Higher Asset Turnover y-y | N |
HALO Number of Guru Trades
HALO Volume of Guru Trades
Gurus Latest Trades with NAS:HALO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:HALO is held by these investors
Total 3
Halozyme Therapeutics Inc Insider Transactions
No Available Data
News about NAS:HALO
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers